[1]
NANDHINI PRIYA.M and PURUSHOTHAMAN.S 2018. Efficacy, safety and cost effectiveness of oral doxofylline and theophylline for mild to moderate persistent bronchial asthma: A randomized prospective open labeled comparative study. International Journal of Pharma and Bio Sciences. 9, 2 (Jun. 2018), 51–56. DOI:https://doi.org/10.22376/ijpbs.2018.9.2.pr51-56.